Transaktionen anzeigen
Gesundheitswesen

InNeuroCo has been acquired by Integer

The owners of InNeuroCo has sold the company to Integer (NYSE:ITGR).

Founded in 2014 and headquartered in Pembroke Pines, Florida, InNeuroCo is a leading founder-owned designer and contract manufacturer of ultra-precise, highly engineered neurovascular catheters. InNeuroCo’s primary products are single-use catheters principally used in interventional neurovascular procedures for the treatment of ischemic strokes and aneurysms. Offering turnkey product design and development, supported by comprehensive domestic manufacturing capabilities, InNeuroCo serves as a mission-critical supply partner to the world’s preeminent medical device OEMs.

With approximately US$1.4 billion in annual revenue, Integer is one of the largest medical devices outsource manufacturers in the world, serving the cardiac, vascular, rhythm management and neuromodulation markets.

Oaklins TM Capital in the US served as the exclusive financial advisor to InNeuroCo in its sale to Integer (NYSE:ITGR).

DIENSTLEISTUNG
PARTEIEN
«InNeuroCo’s founders have enjoyed a long-standing history of success with the Oaklins TM healthcare team. When we began contemplating a transaction for InNeuroCo, it was the obvious choice to serve as our advisor. Throughout this transaction, their knowledge of the neurovascular sector, valuable strategic insights and demonstrated expertise in contract medical manufacturing were critical to engineering a successful outcome for InNeuroCo. We appreciate the team’s tireless dedication and thoughtful approach.»

Marc Litzenberg

President and CEO, InNeuroCo

Sprechen Sie mit dem Deal Team

James McLaren

Managing Director
New York, Vereinigte Staaten
Oaklins TM Capital

Michael S. Goldman

Managing Director
New York, Vereinigte Staaten
Oaklins TM Capital

John Dean

Associate Director
Atlanta, Vereinigte Staaten
Oaklins TM Capital

Bradley S. Goldstein

Associate Director
Atlanta, Vereinigte Staaten
Oaklins TM Capital

Ariel Fieldman

Associate
New York, Vereinigte Staaten
Oaklins TM Capital

Matthew Halbig

Analyst
Atlanta, Vereinigte Staaten
Oaklins TM Capital

Transaktionen

HD Clinical Ltd. has been acquired by NEXUS AG
Gesundheitswesen | TMT

HD Clinical Ltd. has been acquired by NEXUS AG

NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.

Mehr erfahren
Reed Veterinary Surgery has been acquired by Kin Vet Community
Private Equity | Gesundheitswesen

Reed Veterinary Surgery has been acquired by Kin Vet Community

The acquisition of Reed Veterinary Surgery by Kin Vet Community has been successfully completed. Through this acquisition, the surgery joins a community of veterinary clinics where colleagues share knowledge and best practices to improve the wellbeing of their clients and their animals.

Mehr erfahren
PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production
Gesundheitswesen

PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production

PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.

Mehr erfahren